Schedule 13D ownership disclosure

ENZO BIOCHEM INC

Common Stock, par value $0.01 per share · CUSIP: 294100102

Event date: 2025-06-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Harbert Discovery Fund, LPReported CIK 0001626127

    Shares: 1,763,493.00 · Class: 3.36%

  • Harbert Discovery Fund GP, LLCReported CIK 0001642538

    Shares: 1,763,493.00 · Class: 3.36%

  • Harbert Discovery Co-Investment Fund I, LPReported CIK 0001771491

    Shares: 3,412,420.00 · Class: 6.51%

  • Harbert Discovery Co-Investment Fund I GP, LLCReported CIK 0001771499

    Shares: 3,412,420.00 · Class: 6.51%

  • Harbert Fund Advisors, Inc.Reported CIK 0001616659

    Shares: 5,175,913.00 · Class: 9.87%

  • Harbert Management CorporationReported CIK 0001259933

    Shares: 5,175,913.00 · Class: 9.87%

  • Jack Bryant

    Shares: 5,175,913.00 · Class: 9.87%

  • Kenan Lucas

    Shares: 5,175,913.00 · Class: 9.87%

  • Raymond Harbert

    Shares: 5,175,913.00 · Class: 9.87%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002786
Form type
SCHEDULE 13D/A
Filer
ENZO BIOCHEM INC
CIK
CIK 316253
Filed
Jun 25, 2025
Reporting period
Jun 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub